Home › Stocks › OCUL › All Fund Holders
OCUL — OCULAR THERAPEUTIX INC · All Fund Holders
Funds holding (latest): 38 · Reported value held: $922.44M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 32.84M | $322.53M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 19.38M | $190.28M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 11.58M | $140.52M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 5.02M | $49.32M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 3.29M | $32.33M | 0.13% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 3.25M | $31.87M | 0.04% | Add |
| Northern Trust Corp history | Q2 2026 | 1.80M | $17.67M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.76M | $17.30M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 1.55M | $15.23M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.53M | $15.06M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 1.34M | $13.20M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 1.22M | $11.97M | 0.01% | Reduce |
| Franklin Resources history | Q2 2025 | 1.17M | $10.86M | 0.00% | Hold |
| AQR Capital Management history | Q2 2026 | 950.34K | $9.33M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 911.83K | $8.95M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 553.24K | $5.43M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 519.23K | $5.10M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 482.29K | $4.86M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 378.75K | $3.72M | 0.01% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 231.07K | $2.27M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 229.26K | $2.25M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 224.15K | $2.20M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 154.70K | $1.52M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 140.72K | $1.38M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 126.03K | $1.24M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 124.46K | $1.22M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 117.92K | $1.16M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2025 | 73.01K | $886.30K | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 71.50K | $702.14K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 68.50K | $580.54K | 0.00% | Reduce |
| CPP Investments history | Q4 2025 | 35.20K | $427.33K | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 33.70K | $330.93K | 0.00% | Add |
| Millennium Management history | Q1 2026 | 34.01K | $288.03K | 0.00% | Reduce |
| Farallon Capital Management history | Q1 2026 | 18.00K | $152.46K | 0.00% | Hold |
| Principal Global Investors history | Q2 2026 | 13.45K | $132.04K | 0.00% | Reduce |
| Amundi US history | Q1 2026 | 10.59K | $89.69K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 7.62M | $74.86K | 0.01% | Add |
| PNC Financial Services history | Q2 2026 | 957 | $9.40K | 0.00% | Add |